학술논문
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
Document Type
Article
Author
Wray, Sibyl; Then Bergh, Florian; Wundes, Annette; Arnold, Douglas L.; Drulovic, Jelena; Jasinska, Elzbieta; Bowen, James D.; Negroski, Donald; Naismith, Robert T.; Hunter, Samuel F.; Gudesblatt, Mark; Chen, Hailu; Lyons, Jennifer; Shankar, Sai L.; Kapadia, Shivani; Mendoza, Jason P.; Singer, Barry A.
Source
Advances in Therapy; Apr2022, Vol. 39 Issue 4, p1810-1831, 22p
Subject
Language
ISSN
0741238X
Abstract
Copyright of Advances in Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)